Outcomes of Patients With Thyroid Eye Disease Partially Treated With Teprotumumab.
Ho TC, Maamari RN, Kossler AL, Sears CM, Freitag SK, Reshef ER, Shinder R, Rootman DB, Diniz SB, Kahana A, Schlachter D, Do TH, Kally P, Turner S, Mokhtarzadeh A, Harrison AR, Hwang CJ, Kim HJ, Avila SA, Thomas DA, Magazin M, Wester ST, Lee WW, Clauss KD, Holds JB, Sniegowski M, Compton CJ, Briggs C, Malik AI, Lucarelli MJ, Burkat CN, Patel LG, Couch SM.
Ho TC, et al. Among authors: reshef er.
Ophthalmic Plast Reconstr Surg. 2023 Mar-Apr 01;39(2):150-155. doi: 10.1097/IOP.0000000000002267. Epub 2022 Sep 9.
Ophthalmic Plast Reconstr Surg. 2023.
PMID: 36095848
Free PMC article.